Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Basal Cell Nevus Syndrome × gusacitinib × Clear all

Phase

Phase 1/2 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 1 Basal Cell Nevus Syndrome 1

Interventions

sonidegib 3 HhAntag691 3 tazarotene 2 IPI-926 2 Drug Evaluation 2 merphos 1 gusacitinib 1 Vincristine 1 Nivolumab 1 NVP-BKM120 1 Methotrexate 1 Mental Status and Dementia Tests 1 Ipilimumab 1 Etoposide 1 Cyclophosphamide 1 Carboplatin 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04416516 2024-04-10

Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor

Ascend Biopharmaceuticals Ltd

Phase 2 Completed

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡